Letter to the Editor: Discussing ANT1 role in Amyotrophic Lateral Sclerosis pathogenesis
Innov Clin Neurosci. 2018;15(3–4):11–14 Dear Editor: Amyotrophic lateral sclerosis (ALS) [...]
Pimavanserin: A Novel Drug Approved to Treat Parkinson’s Disease Psychosis
by Amanda K. Kitten, PharmD; Sarah A. Hallowell, PharmD; Stephen [...]
Effectiveness of Electroconvulsive Therapy (ECT) in Parkinsonian Symptoms: A Case Series
by Sandeep Grover, MD; Aditya Somani, MD; Neeru Sahni, MD; [...]
Lower-extremity Dynamometry as a Novel Outcome Measure in a Double-blind, Placebo-controlled, Feasibility Trial of Intravenous Immunoglobulin (IVIG) for HIV-associated Myelopathy
by Jessica Robinson-Papp, MD, MS; Mary Catherine George, MM, PhD; [...]
Letter to the editor: Stroke Telerehabilitation in Sicily: a cost-effective approach to reduce disability?
Dear Editor: Various surveillance systems are used to identify stroke [...]
The Neuroscience Report—Vol. 48 (November 30, 2017): Multiple Sclerosis
The latest in neuroscience—sorted and summarized for you Welcome to [...]
Physician Prescribing Practices of Vitamin D in a Psychiatric Hospital
by Kimberly B. Mulcahy, PharmD; Eileen Trigoboff, RN, DNS; Lewis [...]
The Neuroscience Report—Vol. 27 (November 9, 2015): Parkinson’s Disease
The latest in neuroscience—sorted and summarized for you Welcome to [...]
Electroconvulsive Therapy Intervention for Parkinson’s Disease
by Puneet Narang, MD; Anna Glowacki, MD; and Steven Lippmann, [...]
The Neuroscience Report—Vol. 10 (July 6, 2015): Schizophrenia
Welcome to the Neuroscience Report where each week we will [...]